Loading data for XPH — first visit, this takes a few seconds.
State Street SPDR S&P Pharmaceuticals ET... (XPH)
NYSEArca: XPH
· 即時價格 · USD
71.47
+1.32 (1.88%)
收盤價： Sep 02, 2026, 8:00 PM
State Street SPDR S&P Pharmaceuticals ETF（XPH）ETF 價格、持股與分析
| 買價 | 69.6 |
| 市值 | 不適用 |
| AUM | 489.39M |
| 資產淨值 | 70.18 |
| 貝他值 | 0.7 |
| EPS (ttm) | 不適用 |
| 本益比（ttm） | 18.89 |
| 分享出去 | 5.5M |
| 成立日期 | Jun 19, 2006 |
| 賣價 | 71.06 |
| 成交量 | 2,918 |
| 20 日平均成交量 | 114,093 |
| 開盤價 | 70.16 |
| 前收盤價 | 70.15 |
| 當日區間 | 71.11 - 71.11 |
| 52 週範圍 | 45.80 - 74.35 |
| 持股 | 不適用 |
| 總費用率 | 0.35% |
關於 XPH
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
十大持股 25.66 資產%
| 名稱 | 代號 | 重量 |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
股利 股利殖利率 0.47%
| 前股利 | 金額 | 付款日期 |
|---|---|---|
| Jun 22, 2026 | $0.0590 | 不適用 |
| Mar 23, 2026 | $0.0610 | 不適用 |
| Dec 22, 2025 | $0.1130 | 不適用 |
| Sep 22, 2025 | $0.1030 | 不適用 |
| Jun 23, 2025 | $0.0960 | 不適用 |
第 1 頁，共 2 頁